| 000 | 01080 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250517155915.0 | ||
| 264 | 0 | _c20180516 | |
| 008 | 201805s 0 0 eng d | ||
| 022 | _a1945-7197 | ||
| 024 | 7 |
_a10.1210/jc.2017-00096 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLamy, Olivier | |
| 245 | 0 | 0 |
_aResponse to Letter: Severe Rebound-Associated Vertebral Fractures After Denosumab Discontinuation. _h[electronic resource] |
| 260 |
_bThe Journal of clinical endocrinology and metabolism _c06 2017 |
||
| 300 |
_a2112 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 | _aBone Density Conservation Agents |
| 650 | 0 | 4 | _aDenosumab |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aOsteoporosis, Postmenopausal |
| 650 | 0 | 4 | _aOsteoporotic Fractures |
| 650 | 0 | 4 | _aSpinal Fractures |
| 700 | 1 | _aGonzalez-Rodriguez, Elena | |
| 700 | 1 | _aAubry-Rozier, Bérengère | |
| 773 | 0 |
_tThe Journal of clinical endocrinology and metabolism _gvol. 102 _gno. 6 _gp. 2112 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1210/jc.2017-00096 _zAvailable from publisher's website |
| 999 |
_c27250896 _d27250896 |
||